Laird Norton Wetherby Wealth Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
Other funds holding CRL
AI
Laird Norton Wetherby Wealth Management's CRL Position: Q3 2025 in Review
Laird Norton Wetherby Wealth Management increased its Charles River Laboratories (CRL) stake by 0.4% in Q3 2025, buying an estimated $953 and bringing the position to 1,517 shares worth $237K. The position accounts for 0.01% of the portfolio, ranked #825.
Laird Norton Wetherby Wealth Management first reported a position in CRL in Q4 2020 and has held it in 18 quarters since. The position peaked at $799K in Q3 2021. 556 funds tracked by Wall St. Rank hold CRL as of Q3 2025.
- Laird Norton Wetherby Wealth Management held 1,517 shares of Charles River Laboratories worth $237K as of Q3 2025.
- Laird Norton Wetherby Wealth Management bought 6 Charles River Laboratories shares in Q3 2025, an estimated $953.
- Charles River Laboratories made up 0.01% of Laird Norton Wetherby Wealth Management's portfolio in Q3 2025, its #825 holding.
- Laird Norton Wetherby Wealth Management first reported a position in Charles River Laboratories in Q4 2020 and has held it in 18 quarters since.
- Laird Norton Wetherby Wealth Management's Charles River Laboratories position peaked at $799K in Q3 2021.
- 556 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2025.
Based on Laird Norton Wetherby Wealth Management's 13F filing for Q3 2025, filed 14 Nov 2025.